search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • Print
  • ShareThis
  • Text Size

IDSA Practice Guidelines

Practice guidelines are systematically developed statements to assist practitioners and patients in making decisions about appropriate health care for specific clinical circumstances. [Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines, 1990]

Attributes of good guidelines include validity, reliability, reproducibility, clinical applicability, clinical flexibility, clarity, multidisciplinary process, review of evidence, and documentation. [Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines, 1990]

Keyword Search

...

Latest Guidelines

Fever and Infection in Long-term Care Facilities

Status: Current

Residents of long-term care facilities (LTCFs) are at great risk for infection. Most residents are older and have multiple comorbidities that complicate recognition of infection; for example, typically defined fever

Residents of long-term care facilities (LTCFs) are at great risk for infection. Most residents are older and have multiple comorbidities that complicate recognition of infection; for example, typically defined fever is absent in more than one-half of LTCF residents with serious infection. Furthermore, LTCFs often do not have the on-site equipment or personnel to evaluate suspected infection in the fashion typically performed in acute care hospitals. In recognition of the differences between LTCFs and hospitals with regard to hosts and resources present, the Infectious Diseases Society of America first provided guidelines for evaluation of fever and infection in LTCF residents in 2000. The guideline presented here represents the second edition, updated by data generated over the intervening 8 years. It focuses on the typical elderly person institutionalized with multiple chronic comorbidities and functional disabilities (e.g., a nursing home resident). Specific topic reviews and recommendations are provided with regard to what resources are typically available to evaluate suspected infection, what symptoms and signs suggest infection in a resident of an LTCF, who should initially evaluate the resident with suspected infection, what clinical evaluation should be performed, how LTCF staff can effectively communicate about possible infection with clinicians, and what laboratory tests should be ordered. Finally, a general outline of how a suspected outbreak of a specific infectious disease should be investigated in an LTCF is provided. Full Text*Every 12 to 18 months following publication, IDSA reviews its guidelines to determine whether an update is required. This guideline was last reviewed and deemed current as of 04/2013.

Cysticercosis

Status: New Guideline in Development

*Projected Publication, Fall 2017

*Projected Publication, Fall 2017

Cryptococcal Disease

Status: Current

Cryptococcosis is a global invasive mycosis associated with significant morbidity and mortality. These guidelines for its management have been built on the previous Infectious Diseases Society of America guidelines from

Cryptococcosis is a global invasive mycosis associated with significant morbidity and mortality. These guidelines for its management have been built on the previous Infectious Diseases Society of America guidelines from 2000 and include new sections. There is a discussion of the management of cryptococcal meningoencephalitis in 3 risk groups: (1) human immunodeficiency virus (HIV)–infected individuals, (2) organ transplant recipients, and (3) non–HIV‐infected and nontransplant hosts. There are specific recommendations for other unique risk populations, such as children, pregnant women, persons in resource‐limited environments, and those with Cryptococcus gattii infection.  Full text*Every 12 to 18 months following publication, IDSA reviews its guidelines to determine whether an update is required. This guideline was last reviewed and deemed current as of 04/2013.

MRSA - Italian

Status: Current

Linee guida evidence-basedper la gestione deipazienti affetti daStaphylococcus aureus resistente allameticillina (MRSA),le infezionisono state preparateda ungruppo di espertidimalattie infettive Society ofAmerica (IDSA).Le linee guida sonodestinate ad essere utilizzatedaoperatori sanitariche si

Linee guida evidence-basedper la gestione deipazienti affetti daStaphylococcus aureus resistente allameticillina (MRSA),le infezionisono state preparateda ungruppo di espertidimalattie infettive Society ofAmerica (IDSA).Le linee guida sonodestinate ad essere utilizzatedaoperatori sanitariche si occupano dipazienti adultie pediatrici coninfezioni da MRSA.Le linee guidadiscutere lagestionedi una varietà disindromicliniche associatecon la malattia diMRSA, tra cuile infezionicutanee e dei tessutimolli (SSTI),batteriemiaed endocardite, polmonite,infezioniosseeearticolari,e sistema nervoso centrale(SNC)infezioni.Le raccomandazioni sonofornite riguardodosaggiovancomicinae il monitoraggio, la gestionedelle infezionidovute a ceppiMRSAcon ridotta sensibilitàalla vancomicinaefallimenti del trattamentovancomicina.

Directrizes Praticas da Infectious Disease Society

Status: Update in Progress

Estas diretrizes baseadas em evidências para o manejo de infecções por Staphylococcus aureusresistentes à meticilina (MRSA) foram preparadas por um grupo de especialistas da >Infectious Diaseases Society of America (IDSA). As

Estas diretrizes baseadas em evidências para o manejo de infecções por Staphylococcus aureusresistentes à meticilina (MRSA) foram preparadas por um grupo de especialistas da >Infectious Diaseases Society of America (IDSA). As diretrizes destinam-se a profissionais de saúde que atendem a pacientes adultos e crianças com infecções por MRSA. Elas discutem o manejo de várias síndromes clínicas associadas à doença por MRSA, inclusive as infecções de pele e partes moles (IPPM), a bacteremia e a endocardite, a pneumonia, as infecções ósseas e articulares e do sistema nervoso central (SNC). São feitas recomendações quanto à dosagem e monitoramento da vancomicina, ao manejo das infecções por cepas de MRSA com susceptibilidade reduzida à vancomicina e das falhas terapêuticas da vancomicina.

Neutropenic Patients with Cancer- Turkish

Status: Update in Progress

Bu belgegüncellemeleri veilkAmerikaEnfeksiyon HastalıklarıDerneği (IDSA)Ateş ve1997 yılında yayınlananveilkkez2002 yılındagüncellendiNötropeniYönergegenişletir.Kanserli hastalardakemoterapi ile indüklenenateş venötropenideneyimyönetmekantimikrobiyal ajanlarınkullanımı içinbir kılavuz olaraktasarlanmıştır.

Bu belgegüncellemeleri veilkAmerikaEnfeksiyon HastalıklarıDerneği (IDSA)Ateş ve1997 yılında yayınlananveilkkez2002 yılındagüncellendiNötropeniYönergegenişletir.Kanserli hastalardakemoterapi ile indüklenenateş venötropenideneyimyönetmekantimikrobiyal ajanlarınkullanımı içinbir kılavuz olaraktasarlanmıştır.

Influenza Spanish

Status: Update in Progress

Directricespara el tratamiento depersonas con infección porvirus de la influenzafueron elaboradas por unpanel de expertos dela Sociedad de EnfermedadesInfecciosas de Estados Unidos.Las directricesbasadas en pruebasabarcantemasde diagnóstico,tratamiento y la quimioprofilaxiscon medicamentos

Directricespara el tratamiento depersonas con infección porvirus de la influenzafueron elaboradas por unpanel de expertos dela Sociedad de EnfermedadesInfecciosas de Estados Unidos.Las directricesbasadas en pruebasabarcantemasde diagnóstico,tratamiento y la quimioprofilaxiscon medicamentos antivirales,y las cuestionesrelacionadas con la gestióninstitucional para elbroteestacional (ínter)de la influenza.Que están destinadospara uso de médicosentodas las especialidades médicas, conatención directa al paciente,ya que la infeccióndel virus de influenzaes común enlas comunidadesdurante la temporada degripey puede serencontradopor los médicosel cuidado deuna amplia variedad depacientes. Enlace al texto completo

Fever & Neutropenia

Status: Update in Progress

"好中球減少を呈する癌患者に対する"本稿は、米国感染症学会(Infectious Diseases Society of America;IDSA)が1997 年に公表し、2002 年に初回改訂を行った最初の発熱性好中球減少患者に対するガイドラインを更新・拡充するものである。化学療法により引き起こされた発熱性好中球減少症を呈する癌患者の管理の際の抗微生物薬の使用指針として活用されることを意図している。

"好中球減少を呈する癌患者に対する"本稿は、米国感染症学会(Infectious Diseases Society of America;IDSA)が1997 年に公表し、2002 年に初回改訂を行った最初の発熱性好中球減少患者に対するガイドラインを更新・拡充するものである。化学療法により引き起こされた発熱性好中球減少症を呈する癌患者の管理の際の抗微生物薬の使用指針として活用されることを意図している。

Candidiases Spanish

Status: Update in Progress

"Guías de práctica clínica para el manejo de la candidiasis: actualización del 2009, de la Infectious Diseases Society of America"[ektdesignns_placeholder_ID0ENC]

"Guías de práctica clínica para el manejo de la candidiasis: actualización del 2009, de la Infectious Diseases Society of America"[ektdesignns_placeholder_ID0ENC]

C. Difficile- French

Status: Update in Progress

"Directives concernant la pratique clinique en cas d’infection à Clostridium difficile chez l’adulte : Mise à jour 2010 effectuée par la « Society for Healthcare Epidemiology of America (ou SHEA)

"Directives concernant la pratique clinique en cas d’infection à Clostridium difficile chez l’adulte : Mise à jour 2010 effectuée par la « Society for Healthcare Epidemiology of America (ou SHEA) [Société américaine d’épidémiologie hospitalière] et la « Infectious Diseases Society of America (ou IDSA)"Cette ligne directriceest conçue pour améliorerle diagnostic et letraitement de l'infectionà Clostridium difficile(ICD)chez les patients adultes.Un cas deCDIest définie parla présence de symptômes(généralementla diarrhée) etsoit un testde selles positifspour les toxinesde C. difficileou toxigènesde C. difficile,ou les conclusionscoloscopieou histopathologiquerévélantune colitepseudo-membraneuse.En plus dediagnostic et de gestion, les méthodesrecommandées decontrôle des infections etla gestion environnementale del'agent pathogènesont présentés.Lesrecommandations sont fondées surles meilleures preuves disponibleset des pratiques, tel que déterminépar uncomité d'expertsnommés parcommunede karité et del'Infectious Diseases Societyof America(IDSA) (le Groupe d'expertsSHEA-IDSA).L'utilisation de ceslignes directrices peuventêtre touchés parla taille de l'établissement et des ressources, tant financièreset de laboratoire,disponiblesdans le cadreclinique particulière.

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site